SureTrader SureTrader Nadex Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Tracon Pharmaceuticals, Inc. (TCON)

Add TCON Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 2/16/2017 1:47:55 PM - Followers: 4 - Board type: Free - Posts Today: 0

TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases. We are a leader in the field of endoglin biology and are using our expertise to develop antibodies that bind to the endoglin receptor. Our lead product candidate, TRC105, is an anti-endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with inhibitors of the VEGF pathway. Our other product candidates are TRC205, an anti-endoglin antibody that is in preclinical development for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development for the treatment of lung cancer and glioblastoma. Each of our product candidates is expected to complement currently available therapies.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
TCON News: Confidential Treatment Order (ct Order) 02/17/2017 11:50:39 AM
TCON News: Amended Quarterly Report (10-q/a) 02/16/2017 06:07:09 AM
TCON News: Amended Statement of Ownership (sc 13g/a) 02/14/2017 06:09:53 AM
TCON News: Statement of Ownership (sc 13g) 02/13/2017 05:27:12 PM
TCON News: Current Report Filing (8-k) 02/10/2017 06:12:57 AM
#12  Sticky Note TRACON Pharmaceuticals Inc (NASDAQ:TCON) Can Still Recover, Just trendmkr 02/10/17 12:33:47 PM
#14   TCON doses first phase-3 patient in angiosarcoma: DewDiligence 02/16/17 01:47:55 PM
#13   FierceBiotech on phase-2 IST failure: DewDiligence 02/10/17 12:47:40 PM
#12   TRACON Pharmaceuticals Inc (NASDAQ:TCON) Can Still Recover, Just trendmkr 02/10/17 12:33:47 PM
#11   Phase-2 IST for TRC105 fails in glioblastoma: #msg-128581753. DewDiligence 02/09/17 04:29:08 PM
#10   TCON takes new $8M loan from SVB—repays old loan: DewDiligence 02/01/17 06:24:19 PM
#9   TCON is not formally presenting at JPM, but DewDiligence 01/09/17 11:07:31 AM
#8   At 12/31/16, TCON had $44.4M in cash, $8.0M DewDiligence 01/09/17 11:05:50 AM
#7   TCON’s new slide deck—with 12/31/16 cash balance: DewDiligence 01/09/17 11:05:29 AM
#6   TCON obtains SPA for TRC105 in angiosarcoma: #msg-127577935. DewDiligence 01/03/17 08:57:30 AM
#5   TCON bearish 5.25 stocktrademan 06/16/16 02:03:34 PM
#4   $TCON recent news/filings stocktrademan 09/18/15 11:30:44 AM
#3   $TCON recent news/filings stocktrademan 06/19/15 03:46:57 PM
#2   Hit $13 today. Someday more iHubbers will kick ipulator_man 04/14/15 05:13:04 PM
#1   § TCON In @ $12 § ipulator_man 04/12/15 01:40:43 AM